openPR Logo
Press release

Intravenous Solution Compounders Market to Hit USD 4.9 Billion by 2035

10-03-2025 03:46 PM CET | Health & Medicine

Press release from: Future Market Insights

Intravenous Solution Compounders Market

Intravenous Solution Compounders Market

The global Intravenous Solution Compounders Market is on a steady growth trajectory, projected to increase from USD 2.7 billion in 2025 to USD 4.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 6.3%. The rise is driven by growing demand for precise, sterile, and patient-specific IV solutions, as healthcare facilities embrace automation to enhance patient safety and efficiency.

Growing Role of Intravenous Solution Compounders

Intravenous therapy is essential in modern healthcare, but preparing these solutions requires extreme accuracy. Errors in compounding can directly impact patient outcomes, especially in critical care, oncology, and complex drug regimens. To address this, automated and semi-automated IV solution compounders have become vital.

By reducing manual handling, these systems minimize errors, maintain sterility, and improve workflow efficiency, while meeting strict regulatory standards. Their adoption is further supported by the expansion of personalized medicine, which requires tailored formulations for individual patients.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-7532

Countertop Systems Lead the Market

The Countertop modality segment is projected to account for 57.6% of the market in 2025, making it the largest category. Compact and versatile, these devices are designed for direct installation in hospital pharmacies or nursing stations, eliminating the need for large infrastructure.

Hospitals favor countertop systems for their speed, precision, and flexibility in handling variable formulations. They also streamline pharmacists' workflows, reduce contamination risks, and enable on-demand compounding for small to medium volumes. With healthcare providers under constant pressure to optimize efficiency, countertop solutions are expected to remain dominant.

Hospitals as the Largest End Users

The Hospitals segment will hold 62.4% of the market in 2025, reflecting the high demand for IV therapy in inpatient care. Critical care units, oncology departments, and surgical wards depend heavily on automated compounding to ensure consistent, sterile, and error-free medication preparation.

Hospitals are investing heavily in automation technologies, staff training, and sterile compounding infrastructure to meet regulatory standards and improve patient outcomes. As healthcare systems worldwide face rising patient loads, demand for reliable IV compounding systems will continue to grow.

Market Drivers

Several factors are fueling this growth:

- Rising chronic disease prevalence - Cancer, cardiovascular, and metabolic disorders are driving demand for complex IV therapies.
- Medication safety awareness - Hospitals are prioritizing tools that reduce compounding errors.
- Adoption of personalized medicine - Growth in tailored therapies requires flexible compounding technologies.
- Healthcare infrastructure expansion - Especially in emerging economies, driving adoption of advanced systems.
- Technological innovation - Automated and robotic systems are setting new standards for accuracy and efficiency.

Challenges Ahead

Despite the positive outlook, the industry faces hurdles. High equipment costs, supply chain issues, and technical complexities remain barriers for some healthcare providers. Additionally, reimbursement challenges and staff training requirements may slow adoption in certain regions. However, increasing regulatory focus on sterile compounding safety is expected to outweigh these barriers in the long term.

Regional Outlook

- North America leads the market, supported by strong regulatory frameworks, advanced hospital infrastructure, and early adoption of automation.
- Europe is expanding steadily, with government initiatives to reduce sterile compounding risks fueling demand. Germany, France, and the UK remain strong markets.
- Asia-Pacific is the fastest-growing region, with China (8.5% CAGR) and India (7.9% CAGR) driving growth due to rapid healthcare modernization and demand for safer IV therapy solutions.
- Latin America and the Middle East & Africa are gradually adopting IV compounders, particularly in total parenteral nutrition (TPN) and oncology.

Country-Level Insights

- China: 8.5% CAGR, leading global growth
- India: 7.9% CAGR, fueled by healthcare modernization
- Germany: 7.2% CAGR, leading Western Europe
- France: 6.6% CAGR
- UK: 6.0% CAGR
- USA: USD 914.4 million in 2025 → USD 1.5 billion in 2035 at 5.4% CAGR
- Brazil: 4.7% CAGR, steady but slower growth

Competitive Landscape

The market features a mix of established leaders and emerging innovators. Key players include:

- Baxter International Inc.
- ARxIUM
- ICU Medical Inc.
- B. Braun Melsungen AG
- Grifols S.A.
- Pfizer Inc.
- Omnicell Inc.

Established players are focusing on automation, R&D, and strategic collaborations to strengthen their positions. For instance, manufacturers are integrating robotics and smart monitoring features to reduce contamination risk and improve accuracy.

Meanwhile, new and mid-sized manufacturers are entering with cost-effective, compact systems that appeal to emerging markets, where demand for reliable IV therapy continues to rise. This dynamic is creating a balanced competitive environment where both established giants and innovative newcomers contribute to market expansion.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/brochure/rep-gb-7532

Innovation and Technology Trends

The future of IV solution compounding lies in automation, robotics, and hybrid systems. Modern compounders are integrating:

Robotic handling arms to reduce manual intervention
Gravimetric accuracy features for precise dosing
User-friendly interfaces to reduce operator errors
Data connectivity for compliance tracking and workflow optimization

These advancements are particularly crucial for oncology and critical care, where complex and high-risk drug preparations demand the highest precision and safety.

Outlook for 2025-2035

The Intravenous Solution Compounders Market is set for robust growth, driven by global demand for safer, faster, and more accurate IV preparations. Hospitals and specialty clinics will continue to lead adoption, while countertop devices dominate the market.

As healthcare providers worldwide prioritize patient safety, precision medicine, and efficiency, IV solution compounders will remain central to modern hospital pharmacies. Established manufacturers are expected to lead with technological innovation, while new players seize opportunities in emerging markets with cost-effective solutions.

Related Reports:

Orthopaedic Imaging Equipment Market: https://www.futuremarketinsights.com/reports/orthopaedic-imaging-market

Endovenous Laser Therapy Market: https://www.futuremarketinsights.com/reports/endovenous-laser-devices-market

North America and Europe Artificial Pancreas Systems Market: https://www.futuremarketinsights.com/reports/north-america-and-europe-artificial-pancreas-systems-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Solution Compounders Market to Hit USD 4.9 Billion by 2035 here

News-ID: 4207800 • Views:

More Releases from Future Market Insights

External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Driven by Innovation and Expanding Healthcare Access
External Anti-infective Preparations Market USD 6,728.7 Million through 2035, Dr …
The global external anti-infective preparations market is on track for sustained growth, with revenues projected to rise from USD 5,412.8 million in 2025 to approximately USD 6,728.7 million by 2035, representing an absolute increase of USD 1,315.9 million and a compound annual growth rate (CAGR) of 2.2%. This expansion is fueled by the increasing prevalence of external infections and the growing demand for localized antimicrobial treatment solutions across hospitals, clinics,

All 5 Releases


More Releases for CAGR

[CAGR of 6.7%] Nanocoatings Market Size, Industry Share, CAGR, Regional Forecast …
The global Nanocoatings Market generated $10.7 billion in 2020, and is projected to reach $20.1 billion by 2030, growing at a CAGR of 6.7% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends. Download sample PDF @ https://www.alliedmarketresearch.com/request-sample/2064 According to the report published by Allied Market Research,
[CAGR of 5.3%] Pigments Market Size, Industry Share, CAGR, Regional Forecast, 20 …
A recent report by Allied Market Research provides a detailed analysis of the pigments market, highlighting its robust growth. The industry was valued at $27.2 billion in 2022 and is projected to surge to $45.4 billion by 2032, exhibiting an impressive CAGR of 5.3% from 2023 to 2032. This research report identifies the growth drivers behind the market's expansion and delves into the market dynamics using advanced analytical frameworks
Enzymes Market Expansion CAGR of 4.9% CAGR Anticipated 2025-2034
The Enzymes Market report is an in-depth examination of the global Enzymes Market's general consumption structure, development trends, sales techniques, and top nations' sales. The research looks at well-known providers in the global Enzymes Market industry, as well as market segmentation, competition, and the macroeconomic climate. A complete Enzymes Market analysis takes into account a number of aspects, including a country's population and business cycles, as well as market-specific microeconomic
Waterproofing Membranes Market is Projected Grow at CAGR of 8% CAGR by 2033
The waterproofing membranes market is anticipated to witness a Compound Annual Growth Rate (CAGR) of 8.0% over the forecast period. By 2023, the estimated market value for waterproofing membranes is substantial, reaching US$ 31.5 billion. These waterproofing materials comprise thin, impermeable membranes designed to collaborate with asphalt, providing a protective shield for the structural integrity of buildings. The asphalt component in these membranes acts as a safeguard, preserving the underlying membrane
Electric Bed Market CAGR, Size, Share Grow USD 2,063 Million by 2030 CAGR 13.70%
Global electric bed market size is expected to be worth roughly USD 2,063 million by 2030, growing at a CAGR of more than 13.7% during the projected timeframe of 2022-2030, according to Ameco Research A significant portion of the population over the age of 60, who often have reduced immunity levels and are more susceptible to neurological disorders, cardiac issues, tumors, and spinal cord compression, is anticipated to have a substantial
Pediatric Radiology Market Size will Grow at CAGR 7.7% CAGR during 2017-2026
Pediatric Radiology Market:Overview The pediatric radiology market is likely to register robust growth in the near future. Chronic illnesses among children including neurological disorders such as ADHD are on the rise. According to the US labor bureau, the demand for pediatrician is expected to grow by 24% on average by 2020. This is the highest average growth among all professionals in the United States. Despite challenges such as training for new